











































Widespread spontaneous hyperproliferation, melanosis and
melanoma in Hgf-Cdk4R24C mice
Citation for published version:
van der Weyden, L, Arends, M, Brenn, T, Tüting, T & Adams, D 2018, 'Widespread spontaneous
hyperproliferation, melanosis and melanoma in Hgf-Cdk4R24C mice', Melanoma Research, vol. 28, no. 1.
https://doi.org/10.1097/CMR.0000000000000414
Digital Object Identifier (DOI):
10.1097/CMR.0000000000000414
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 23. Jul. 2021
Letter to the Editor
Melanoma Research 2018, 28:76–78
Widespread spontaneous hyperproliferation,
melanosis and melanoma in
Hgf-Cdk4R24C mice
Louise van der Weydena,*, Mark J. Arendsb,*, Thomas Brennc,*,
Thomas Tuting
d




Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
Cambridge, bCentre for Comparative Pathology, Cancer Research UK Edinburgh
Centre, Division of Pathology, Institute of Genetics and Molecular Medicine,
cPathology Department, Western General Hospital, Edinburgh, UK
and dDepartment of Dermatology, University Hospital Magdeburg, Magdeburg,
Germany
Correspondence to Louise van der Weyden, PhD, Experimental Cancer Genetics,
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
Cambridge CB10 1SA, UK
Tel: + 44 122 383 4244; fax: + 44 122 349 6802; e-mail: lvdw@sanger.ac.uk
*Louise van der Weyden, Mark J. Arends and Thomas Brenn contributed equally
to the writing of this article.
Received 27 July 2017 Accepted 27 October 2017
Seeking a model of spontaneous metastatic melanoma,
we imported the Hgf-Cdk4R24C mouse line in which
overexpression of hepatocyte growth factor (Hgf) promotes
melanocyte proliferation and migration and the clinically
relevant mutation in cyclin-dependent kinase 4 (Cdk4R24C)
prevents binding to the tumor suppressor protein p16 [1].
These mice have been reported to spontaneously develop a
spectrum of primary melanomas, with 61% showing pro-
gressively growing melanomas at 1 year of age (74% nodular
melanomas, 26% flat melanomas) [2]. The tumours appear
mostly on the back (80%) and more rarely in other locations
such as the ear, nose, belly, extremities, anus and tail
(2–5%/site), with metastasis into the draining lymph nodes
in all mice [2]. More recently, a study of the eyes of
11-month-old Hgf-Cdk4R24C mice found altered corneal
stromal morphology, but no evidence of spontaneous ocular
melanoma [3].
In our facility, Hgf-Cdk4R24C/R24C mice were generated by
intercrossingHgf-Cdk4R24C/R24Cmale mice with Cdk4R24C/R24C
female mice (C57BL/6 background; the use and housing
conditions of mice are detailed in Supplementary Data
Table 1 (Supplemental digital content 1, http://links.lww.com/
MR/A20)). Females were predominantly used in this study as
litters from this mouse line were typically small and mice
carrying the Hgf allele had sub-Mendelian ratios. Thus, to
avoid having singly housed males (in the case of only one
male from a litter carrying the Hgf allele), we mostly kept
females for tumour watch studies as they could be group
housed irrespective of their age. Hgf-Cdk4R24C/R24C mice
(12 females, 3 males) were left to age with daily visual
inspections, and typically were killed because of hyperpro-
liferation of their anogenital areas at 341±61 days of
age (range: 178−429 days). At the time of necropsy, we
observed a range of tissue sites undergoing hyperprolifera-
tion, with the presence of melanosis and the development
of melanoma (and other tumours) in many cases (Table 1).
All mice showed mixed anal mucosal melanoma/perianal
skin malignant melanoma (Fig. 1a–c) with concomitant
vulval/penile mucosal melanoma (Fig. 1d and e). Both flat
and papillary skin melanomas (Fig. 1f) were noted in all
mice, with a few cases of nodular melanoma (Fig. 1g). A high
incidence of mucosal melanoma of the lips was also
observed, as well as two cases of mucosal melanoma of the
snout. Opacity and ulcerations of the eyes and/or discharge
from the eyes were a recurrent observation; all eyes sampled
showed retinal melanosis (Fig. 1h) with increased melanin
pigmentation of the retinal pigment epithelium (and usually
the iris/uveal tract), some with a possible increase in numbers
of retinal pigment epithelial cells, but no evidence of inva-
sive melanoma of the retina or the uveal tract (with one case
showing a concomitant conjunctival melanoma). All hard-
erian glands sampled showed hyperplasia and adenoma
formation (sometimes >1). All brains sampled showed
Table 1 Tissue distribution and frequency of melanosis and tumour
development in Hgf-Cdk4R24C/R24C mice
Pathology Frequency [n/N (%)]
Perianal skin melanoma/anal canal mucosal
melanoma
15/15 (100)
Vulval mucosal melanoma 12/12 (100)a
Penile melanoma 3/3 (100)
Skin nodular melanoma 3/15 (20)
Skin flat melanoma 15/15 (100)
Skin papillary melanoma 15/15 (100)
Lip mucosal melanoma 12/15 (80)
Snout mucosal melanoma 2/15 (13)
Eye harderian gland hyperplasia and adenoma 14/14 (100)b
Eye retinal melanosis 14/14 (100)b,c
Brain meningeal melanosis 14/14 (100)b
Liver hepatocellular carcinoma 2/15 (13)
Lymph node metastatic melanoma 10/15 (66)d
Cdk4, cyclin-dependent kinase 4; Hgf, hepatocyte growth factor.
aOne mouse also developed a uterine/cervical melanoma.
bFor one mouse, the eyes, harderian gland and brain were not collected for
analysis.
cOne mouse also developed conjunctival melanoma.
d5/15 (33%) mice showed the presence of pigmented macrophages in lymph
nodes, but no definite melanoma.
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Fig. 1
Macroscopic and histological images of tissue melanosis and melanoma in Hgf-Cdk4R24C mice. (a) Macroscopic image of a perianal (and vulval)
melanoma (the scale bar is 0.4 cm). (b, c) Haematoxylin and eosin (H&E)-stained section of a perianal melanoma, showing a papillary melanoma with
both junctional and dermal melanoma components with the melanoma extending up around the anal canal close to the anorectal junction (the scale
bar is 1 mm, b), and showing invasion of atypical, malignant, heavily pigmented melanoma cells into muscle (the scale bar is 50 μm, c).
(d) Macroscopic image of a vulval (and anal) melanoma (the scale bar is 0.4 cm). (e) Macroscopic image of a penile melanoma (the scale bar is
0.4 cm). (f) H&E-stained section of a skin papillary melanoma, showing junctional and dermal melanomatous components admixed with squamous
epithelium and keratinous material showing a papillomatous architecture (the scale bar is 1 mm). (g) H&E-stained section of skin showing nodular
melanoma in the subepithelial tissue, mostly heavily pigmented with a few small oval foci of loss of pigmentation (the scale bar is 1 mm). (h) H&E-
stained section of retinal melanosis, showing a thickened and prominent pigmented layer under the retina because of overactivity of the retinal pigment
epithelium with pigment extending into the underlying muscle and other tissue (the scale bar is 50 μm). (i) Macroscopic image of a brain showing
meningeal melanosis (the scale bar is 0.4 cm). (j) H&E-stained section of meningeal melanosis, showing variably increased pigment within the thin
meningeal layer on the surface of the brain (the scale bar is 1 mm). All images are representative of those observed across the cohort (as detailed in
Table 1). Cdk4, cyclin-dependent kinase 4; Hgf, hepatocyte growth factor.
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meningeal melanosis with increased melanin pigmentation
of the meninges, some with a probable increase in numbers
of meningeal melanocytes, but no evidence of invasive
melanoma infiltrating brain tissue (Fig. 1i and j). A few livers
showed hepatocellular carcinoma and most livers showed
increased melanin pigment. Metastasis to the lymph nodes
was noted in 10/15 mice, with the remaining 5/15 mice
showing the presence of pigmented macrophages in the
lymph nodes.
Thus, in our facility, we had an increased incidence of
mucosal melanoma, retinal melanosis and brain meningeal
melanosis in preference to cutaneous melanoma, which is
in contrast to previous reports [2], although spontaneous
melanocytic hyperplasia of the mucosa, particularly of the
perianal and genital mucosa, has been observed pre-
viously, but not reported (Thomas Tuting, unpublished
observations). Also, the cutaneous melanomas that we
observed were of the flat and/or papillary types, less
commonly the nodular type, which has been reported
previously to be the predominant one. Finally, we did not
find any alterations in pigmentation or cellular compo-
nents of the ocular epithelium or the posterior segment
that have been reported previously [3]. Essentially, the
oncogenic mutation in this model appears to be capable of
driving almost all melanocytes to hyperproliferation and
subsequent neoplasia, with more neoplasia in some sites
than others depending on whether additional mutational
events are required. The reason for a shift in phenotype
between the animal facilities is unclear and further
investigation is undoubtedly warranted. Although these
mice were maintained on a C57BL/6J background, we
cannot account for genetic drift of the C57BL/6J colonies
between the different institutes, which could influence
tumour growth [4]. It is tempting to speculate that envir-
onmental factors such as differences in the housing
conditions of the mice between the two facilities (detailed
in Supplementary Data Table 1, Supplemental digital
content 1, http://links.lww.com/MR/A20) may be playing a
role as these factors have been shown to affect tumour
growth [4]; indeed, the presence of harderian gland
hyperplasia and adenoma formation has been observed
in aged mice from other lines in our facility. Similarly,
the microbiota of the mice, which would undoubtedly
differ between the two facilities, affect many aspects of
physiology, most importantly tumour–immune cell inter-
actions, and thus can play a major role in regulating the
initiation, progression and dissemination of cancer [5].
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